Buprenorphine supply stable during pandemic, as methadone supply dropped

The buprenorphine supply in the United States has remained stable, while the methadone supply has consistently dropped during the COVID-19 pandemic, researchers reported in JAMA Network Open.
Annie Y. Chen, DDS, MS, an assistant policy researcher at the RAND Corp. in Boston, and colleagues investigated whether the COVID-19 pandemic was associated with the disruption of buprenorphine and methadone supplies in the United States.
Buprenorphine and methadone are the most effective treatments available for those who have an opioid use disorder, the authors wrote. Delays in medication access may

The buprenorphine supply in the United States has remained stable, while the methadone supply has consistently dropped during the COVID-19 pandemic, researchers reported in JAMA Network Open.
Annie Y. Chen, DDS, MS, an assistant policy researcher at the RAND Corp. in Boston, and colleagues investigated whether the COVID-19 pandemic was associated with the disruption of buprenorphine and methadone supplies in the United States.
Buprenorphine and methadone are the most effective treatments available for those who have an opioid use disorder, the authors wrote. Delays in medication access may